keyword
https://read.qxmd.com/read/38419701/case-report-tolosa-hunt-syndrome-expanding-the-neuromyelitis-optica-spectrum-disorder-phenotype
#21
Soo-Hyun Park, Soo-Im Jang, Eun-Ja Lee, Nam-Hee Kim
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathy caused by the autoantibody of aquaporin-4 (AQP4). Herein, we report a case of Tolosa-Hunt syndrome presenting with abducens palsy and AQP4 antibodies. This was a rare case of AQP4-immunoglobulin G seropositivity in a patient with Tolosa-Hunt syndrome. Our findings may expand the clinical phenotype of NMOSD and indicate that clinicians should consider testing for AQP4 antibodies in patients with Tolosa-Hunt syndrome.
2024: Frontiers in Neurology
https://read.qxmd.com/read/38418215/prognostic-factors-of-first-onset-optic-neuritis-based-on-diagnostic-criteria-and-antibody-status-a-multicentre-analysis-of-427-eyes
#22
JOURNAL ARTICLE
Young Gi Min, Yeji Moon, Young Nam Kwon, Byung Joo Lee, Kyung-Ah Park, Jae Yong Han, Jinu Han, Haeng-Jin Lee, Seol-Hee Baek, Byung-Jo Kim, Jun-Soon Kim, Kyung Seok Park, Nam-Hee Kim, Martha Kim, Tai-Seung Nam, Seong-Il Oh, Jae Ho Jung, Jung-Joon Sung, Myoung-Jin Jang, Seong-Joon Kim, Sung-Min Kim
BACKGROUND: Optic neuritis (ON) prognosis is influenced by various factors including attack severity, underlying aetiologies, treatments and consequences of previous episodes. This study, conducted on a large cohort of first ON episodes, aimed to identify unique prognostic factors for each ON subtype, while excluding any potential influence from pre-existing sequelae. METHODS: Patients experiencing their first ON episodes, with complete aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibody testing, and clinical data for applying multiple sclerosis (MS) diagnostic criteria, were enrolled...
February 28, 2024: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/38398485/treatment-and-rehabilitation-of-a-patient-with-neuromyelitis-optica-spectrum-disorder-induced-complete-spinal-cord-injury-following-covid-19-vaccination-a-case-report
#23
Jun-Sang Han, Seong-Mun Ryu, Young-Hwan Lim, Ae-Ryoung Kim, Tae-Du Jung
Neuromyelitis optica spectrum disease (NMOSD) is a rare autoimmune disorder of the central nervous system characterized by optic neuritis, myelitis, or brain lesions. Its symptoms overlap with those of multiple sclerosis (MS), making a diagnosis of NMOSD challenging. Here, we report a rare case of NMOSD-induced complete spinal cord injury following COVID-19 vaccination. A 52-year-old female patient developed NMOSD-induced complete spinal cord injury after receiving their third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2)...
February 19, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38359691/retinal-structural-and-microvascular-deterioration-independent-of-optic-neuritis-in-aquaporin-4-antibody-positive-neuromyelitis-optica-spectrum-disorders-an-optical-coherence-tomography-angiography-study
#24
JOURNAL ARTICLE
Meng Wang, Wenjun Wang, Sihua Liu, Jin Ma, Xuqian Wang, Yuyu Chou, Linyang Gan, Xia Zhang, Enhua Shao, Yong Zhong, Yan Xu
PURPOSE: To assess the retinal structural and microvascular change in aquaporin-4 antibody (AQP4) positive neuromyelitis optica spectrum disorder (NMOSD) patients and the correlation with clinical features. METHODS: A cross-sectional study was performed with optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) to measure retinal structure and microvascular parameters in AQP4 positive NMOSD patients. RESULTS: Sixty-two NMOSD patients (44 eyes with ON, NMOSD+ON; 77 eyes without ON, NMOSD-ON) and 62 healthy controls (HC, 124 eyes) were included...
January 6, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38343712/regional-spinal-cord-volumes-and-pain-profiles-in-aqp4-igg%C3%A2-%C3%A2-nmosd-and-mogad
#25
JOURNAL ARTICLE
Susanna Asseyer, Ofir Zmira, Laura Busse, Barak Pflantzer, Patrick Schindler, Tanja Schmitz-Hübsch, Friedemann Paul, Claudia Chien
OBJECTIVE: Aquaporin-4-antibody-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder (MOGAD) are relapsing neuroinflammatory diseases, frequently leading to chronic pain. In both diseases, the spinal cord (SC) is often affected by myelitis attacks. We hypothesized that regional SC volumes differ between AQP4-IgG + NMOSD and MOGAD and that pain intensity is associated with lower SC volumes...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38342798/visualization-and-analysis-of-mapping-knowledge-domains-for-optic-neuritis-a-bibliometric-research-from-2013-to-2022
#26
JOURNAL ARTICLE
Bo Jiang, Nan Hong, Fangkun Zhao, Feng Dong
PURPOSE: To explore the global research trends, hotspots and frontiers of optic neuritis (ON) over the past decade through qualitative and quantitative analysis of bibliometrics. METHODS: Publications on ON from 2013 to 2022 were retrieved from Web of Science Core Collection (WoSCC). VOSviewer and CiteSpace were mainly used to facilitate bibliometric analysis and visualization. RESULTS: A total of 3027 papers were retrieved from peer-reviewed publications and the annual research output increased over time...
February 12, 2024: International Ophthalmology
https://read.qxmd.com/read/38313959/optic-chiasm-glioma-in-an-older-adult-patient
#27
Ulviyya Gasimova, Osasu Adah, Matahi Muradova, Kaleigh Roberts, Sonika Dahiya, Rashmi Verma, Lokesh Rukmangadachar
We present a case of an adult patient experiencing progressive visual loss. An initial presentation was concerning for neuromyelitis optica with optic chiasm involvement. However, persistent contrast enhancement observed in follow-up brain and orbit images raised suspicion for optic tract malignant neoplasm. Histopathological evolution of optic nerve biopsy confirmed the diagnosis of an optic chiasm glioma. The patient was then referred to oncology for chemotherapy.
January 2024: Curēus
https://read.qxmd.com/read/38312734/advances-in-the-long-term-treatment-of-neuromyelitis-optica-spectrum-disorder
#28
REVIEW
Monique Anderson, Michael Levy
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neuroinflammatory disorder with a prevalence of 1-5/100,000 globally, characterized by attacks of the central nervous system including but not limited to optic neuritis, transverse myelitis and brainstem lesions, including area postrema lesions. These autoimmune attacks can lead to irreversible damage if left untreated, therefore strategies have been developed to prevent relapses. Initial off-label treatments have achieved variable levels of success in relapse prevention, but improved relapse prevention and quality of life remain a goal in the field...
2024: Journal of Central Nervous System Disease
https://read.qxmd.com/read/38279789/prevalence-of-neuromyelitis-optica-spectrum-disorder-in-the-united-states
#29
JOURNAL ARTICLE
Farren Bs Briggs, Jacqueline Shaia
BACKGROUND: Neuromyelitis optic spectrum disorder (NMOSD) is a rare demyelinating, autoimmune disease and the burden in United States is not well characterized. OBJECTIVE: The objective of this study was to determine the 2022 US prevalence of NMOSD. METHODS: We constructed a cross-sectional study using aggregated electronic health record data for 25.7 million patients who had a 2022 clinical encounter. The data originated from the TriNetX US Collaborative Network of 55 healthcare organizations that span all 50 states...
January 27, 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38234168/ophthalmic-manifestations-of-biotinidase-deficiency-report-of-a-case-and-review-of-literature
#30
REVIEW
Fatemeh Abdi, Sadaf Parvin, Vahid Zare Hosseinabadi, Maryam Kachuei, Arzhang Gordiz, Sara Hemmati, Parvaneh Karimzadeh
INTRODUCTION: Biotinidase deficiency (BD) is an inherited autosomal recessive metabolic disorder. BD has been associated with optic nerve atrophy, eye infections, and retinopathy. The most prevalent ophthalmic manifestation of BD is optic atrophy, which might be misdiagnosed as multiple sclerosis or neuromyelitis optica, especially in late-onset BD cases. METHODS: In this article, we report a 9-year-old boy with gradual vision loss. Ophthalmologic examination, Brain MRI, and several laboratory tests such as Aquaporin-4 IgG level and biotinidase level were done on the patient...
January 17, 2024: Ophthalmic Genetics
https://read.qxmd.com/read/38224478/efficacy-and-safety-of-the-natural-killer-t-cell-stimulatory-glycolipid-och-ncnp1-for-patients-with-relapsing-multiple-sclerosis-protocol-for-a-randomized-placebo-controlled-clinical-trial
#31
JOURNAL ARTICLE
Tomoko Okamoto, Takami Ishizuka, Reiko Shimizu, Yasuko Asahina, Harumasa Nakamura, Yuko Shimizu, Yoichiro Nishida, Takanori Yokota, Youwei Lin, Wakiro Sato, Takashi Yamamura
BACKGROUND: Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system that causes myelin sheath damage and axonal degeneration. The glycolipid (2S, 3S, 4R)-1-O-(α-d-galactosyl)-2-tetracosanoylamino-1,3,4-nonaetriol (OCH-NCNP1 or OCH) exerts an immunoregulatory action that suppresses T helper (Th)1 cell-mediated immune responses through natural killer T cell activation, selective interleukin-4 production, and Th2 bias induction in human CD4-positive natural killer T cells...
January 15, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38217965/visual-outcome-measures-in-pediatric-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-mogad
#32
JOURNAL ARTICLE
Flavia C Gericke, James V M Hanson, Annette Hackenberg, Christina Gerth-Kahlert
BACKGROUND: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) comprises various age-dependent clinical phenotypes and may be monophasic, multiphasic, or chronic. Optic neuritis (ON) is a common manifestation and frequently appears in combination with other MOGAD phenotypes, particularly in young children. Despite permanent structural damage to the retinal nerve fiber layer (RNFL), children often experience complete visual recovery. AIMS: To analyze the progression and impact of MOGAD on the visual system of pediatric patients independently of the history of ON...
January 2024: European Journal of Paediatric Neurology: EJPN
https://read.qxmd.com/read/38216632/early-involvement-of-peripherally-derived-monocytes-in-inflammation-in-an-nmo-like-mouse-model
#33
JOURNAL ARTICLE
Moonhang Kim, Won Seok Kim, Hyeuk Cha, Boram Kim, Young Nam Kwon, Sung Min Kim
Neuromyelitis optica (NMO) is an autoimmune inflammatory disease that primarily affects the optic nerve and spinal cord within the central nervous system (CNS). Acute astrocyte injury caused by autoantibodies against aquaporin 4 (NMO-IgG) is a well-established key factor in the pathogenesis, ultimately leading to neuronal damage and patient disability. In addition to these humoral immune processes, numerous innate immune cells were found in the acute lesions of NMO patients. However, the origin and function of these innate immune cells remain unclear in NMO pathogenesis...
January 12, 2024: Scientific Reports
https://read.qxmd.com/read/38185760/risk-factors-and-prognosis-of-orotracheal-intubation-in-aquaporin-4-igg-neuromyelitis-optica-spectrum-disorder-attacks
#34
JOURNAL ARTICLE
Edouard Januel, Vincent Brochard, Loïc Le Guennec, Elisabeth Maillart, Céline Louapre, Catherine Lubetzki, Nicolas Weiss, Sophie Demeret, Caroline Papeix
BACKGROUND: Aquaporin-4 immunoglobulin G Neuro Myelitis Optica spectrum disorders attacks (NMOSD-AQP4-IgG+ attacks) can cause respiratory failure requiring orotracheal intubation (OTI), but the risk factors and outcomes of OTI during attacks remain unclear. Our primary objective was to identify the clinical and radiological risk factors for OTI in NMOSD-AQP4-IgG+ attacks. As a secondary objective, we aimed to evaluate the prognosis of OTI-attacks. METHODS: We retrospectively analyzed NMOSD-AQP4-IgG+ attacks at the Pitié-Salpêtrière Hospital (Jan 2010-Jan 2021), excluding isolated optic neuritis...
January 8, 2024: Annals of Intensive Care
https://read.qxmd.com/read/38178155/large-molecules-from-the-cerebrospinal-fluid-enter-the-optic-nerve-but-not-the-retina-of-mice
#35
JOURNAL ARTICLE
Xiao J Tong, Gokhan Akdemir, Meetu Wadhwa, Alan S Verkman, Alex J Smith
It has been proposed that cerebrospinal fluid (CSF) can enter and leave the retina and optic nerve along perivascular spaces surrounding the central retinal vessels as part of an aquaporin-4 (AQP4) dependent ocular 'glymphatic' system. Here, we injected fluorescent dextrans and antibodies into the CSF of mice at the cisterna magna and measured their distribution in the optic nerve and retina. We found that uptake of dextrans in the perivascular spaces and parenchyma of the optic nerve is highly sensitive to the cisternal injection rate, where high injection rates, in which dextran disperses fully in the sub-arachnoid space, led to uptake along the full length of the optic nerve...
January 4, 2024: Fluids and Barriers of the CNS
https://read.qxmd.com/read/38174189/when-sight-and-cancer-collide-a-rare-case-of-paraneoplastic-bilateral-optic-neuritis
#36
Jorge Nadal Bosch, Mario Moya, Samuel Serna, Roberto A Cruz, Javier Malcolm
Bilateral acute optic neuritis is a rare and challenging clinical presentation, often associated with conditions like multiple sclerosis or neuromyelitis optica spectrum disorder. We present the case of a 40-year-old woman with a complex medical history, including poorly differentiated squamous cell carcinoma of the cervix (stage IIIC), who presented with a swift and profound bilateral vision loss. Despite initial treatment with high-dose methylprednisolone and therapeutic plasma exchange, her optic nerve enhancement on MRI and negative autoantibody results raised suspicion of paraneoplastic optic neuritis...
December 2023: Curēus
https://read.qxmd.com/read/38165361/prevalence-demographic-and-clinical-factors-associated-with-cognitive-dysfunction-in-patients-with-neuromyelitis-optica-spectrum-disorder
#37
JOURNAL ARTICLE
Luka Vlahovic, Jamie McDonald, Jessica Hinman, Anna Tomczak, Christopher Lock, Chella A Palmer, Lawrence J Cook, Michael R Yeaman, Melinda K Burnett, Gayle K Deutsch, Lorene M Nelson, May H Han
BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorder (NMOSD) is a chronic CNS demyelinating autoimmune disorder targeting the astrocyte antigen aquaporin-4 (AQP4), typically presenting with optic neuritis, transverse myelitis, and brain syndromes. Cognitive dysfunction (CD) in NMOSD is under-recognized and poorly understood. The purpose of this study was to evaluate the prevalence and clinical variables associated with CD in NMOSD. METHODS: This observational retrospective study with longitudinal follow-up describes a clinical cohort seen in the Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD...
January 9, 2024: Neurology
https://read.qxmd.com/read/38165267/-in%C3%A2-vivo-corneal-confocal-microscopy-for-detecting-corneal-nerve-fiber-changes-in-patients-with-different-types-of-optic-neuritis-a-cross-sectional-study
#38
JOURNAL ARTICLE
Rui Zhao, Leying Wang, Fei Chen, Hongjuan Liu, Chunli Chen, Jing Zhang, Sitong Guo, Qingfeng Liang, Libin Jiang
PURPOSE: Optic neuritis (ON), a demyelinating disease of the central nervous system, is often a precursor manifestation of neuromyelitis optica spectrum disorders (NMOSD) or multiple sclerosis (MS). Reduced corneal nerve fiber counts have been found in patients with NMOSD or MS. This study aimed to observe and compare the corneal subbasal nerve plexus in patients with three types of ON and controls without ON using in vivo corneal confocal microscopy (IVCM). METHODS: Data were analyzed for 77 eyes of 48 patients with ON, grouped according to seropositivity for anti-aquaporin-4 IgG, myelin oligodendrocyte glycoprotein antibody, or no seropositivity, and 35 healthy eyes in the control group...
January 2, 2024: Current Eye Research
https://read.qxmd.com/read/38157878/reshaping-neuroimmunology-diagnosis-and-treatment-in-the-era-of-precision-medicine
#39
REVIEW
Giordani Rodrigues Dos Passos, Tarso Adoni, Maria Fernanda Mendes, Douglas Kazutoshi Sato
Precision medicine has revolutionized the field of neuroimmunology, with innovative approaches that characterize diseases based on their biology, deeper understanding of the factors leading to heterogeneity within the same disease, development of targeted therapies, and strategies to tailor therapies to each patient. This review explores the impact of precision medicine on various neuroimmunological conditions, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), optic neuritis, autoimmune encephalitis, and immune-mediated neuropathies...
December 2023: Arquivos de Neuro-psiquiatria
https://read.qxmd.com/read/38134369/serum-biomarker-profiles-discriminate-aqp4-seropositive-and-double-seronegative-neuromyelitis-optica-spectrum-disorder
#40
JOURNAL ARTICLE
Sara Carta, Alessandro Dinoto, Marco Capobianco, Paola Valentino, Francesca Montarolo, Arianna Sala, Markus Reindl, Marianna Lo Re, Vanessa Chiodega, Pierre Branger, Bertrand Audoin, Jennifer Aboab, Caroline Papeix, Nicolas Collongues, Philippe Kerschen, Helene Zephir, Alain Créange, Bertrand Bourre, Kathrin Schanda, Eoin P Flanagan, Vyanka Redenbaugh, Javier Villacieros-Álvarez, Georgina Arrambide, Alvaro Cobo-Calvo, Sergio Ferrari, Romain Marignier, Sara Mariotto
BACKGROUND AND OBJECTIVES: Glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) serum levels are useful to define disease activity in different neurologic conditions. These biomarkers are increased in patients with aquaporin-4 antibody-positive NMOSD (AQP4+NMOSD) during clinical attacks suggesting a concomitant axonal and glial damage. However, there are contradictory results in double seronegative NMOSD (DS-NMOSD). The aim of this study was to characterize the neuronal, axonal, and glial damage of DS-NMOSD in comparison with AQP4+NMOSD...
January 2024: Neurology® Neuroimmunology & Neuroinflammation
keyword
keyword
61149
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.